Where The Selling Ran Deepest: 25 Stocks At 52-Week Lows
A list of market lows raises the classic question of whether a falling price signals damage or opportunity.
Weakness was concentrated in Building Products and Mortgage REITs today, with each sector contributing 3 names to a list of 25 stocks from the Russell 3000 at new 52-week lows. The largest company hitting a new low is Synopsys (SNPS), with a market value of about $71.3 billion. Its 16.5% decline over the last month stands out when the S&P 500 has returned -0.7%.
The central question is what kind of business hits a 52-week low. Is it a broken company, or a growing one that has been marked down? The full list follows.
Thursday’s Full 52-Week-Low List
Here are all 25 names, sorted by market capitalization, with returns over four windows:
| Tickers | Market Cap |
1D % Chg |
1W % Chg |
1M % Chg |
1Y % Chg |
|---|---|---|---|---|---|
| SNPS | $71.3 Bil | -0.4% | -0.3% | -16.5% | -41.4% |
| ALNY | $27.3 Bil | -28.3% | -23.5% | -31.7% | -37.8% |
| ROL | $18.5 Bil | -1.0% | -2.8% | -8.1% | -32.3% |
| LII | $14.5 Bil | -2.9% | -22.4% | -27.1% | -34.0% |
| MAIR | $14.2 Bil | -7.9% | -19.7% | -25.3% | n/a |
| WSO | $11.8 Bil | -2.9% | -13.7% | -24.8% | -30.9% |
| PSKY | $8.7 Bil | -1.8% | -8.0% | -20.8% | n/a |
| HLI | $8.5 Bil | -7.7% | -6.9% | -4.3% | -32.0% |
| BLDR | $7.3 Bil | -2.6% | -6.4% | -26.2% | -50.5% |
| LKQ | $5.8 Bil | -14.4% | -8.9% | -14.2% | -22.7% |
| OTF | $4.6 Bil | -0.8% | -0.6% | -4.6% | -26.6% |
| PFSI | $4.0 Bil | -11.8% | -8.2% | -12.9% | -19.1% |
| BXMT | $2.5 Bil | -8.7% | -9.2% | -11.7% | -14.5% |
| CALX | $2.3 Bil | -1.0% | -1.6% | -5.7% | -37.4% |
| BRSL | $1.9 Bil | -1.7% | -1.5% | -5.1% | -29.4% |
| WINA | $1.2 Bil | -0.9% | -1.3% | -21.7% | -8.7% |
| OI | $1.1 Bil | -4.5% | -17.8% | -23.7% | -49.2% |
| PZZA | $1.0 Bil | -1.2% | -0.4% | -17.8% | -24.9% |
| ABR | $0.9 Bil | -5.7% | -4.6% | -11.6% | -54.0% |
| PMT | $0.8 Bil | -3.9% | -2.8% | -14.2% | -12.9% |
| LCLN | $0.7 Bil | -7.0% | -9.5% | -14.4% | n/a |
| FISN | $0.6 Bil | -1.0% | -9.8% | -12.9% | -12.7% |
| CCB | $0.6 Bil | -43.5% | -44.1% | -48.5% | -58.9% |
| SPRY | $0.6 Bil | -3.4% | -6.2% | -29.7% | -68.3% |
| HTZ | $0.5 Bil | -0.9% | -13.1% | -26.9% | -75.3% |
Some names on this list are still growing at a high rate.
Alnylam Pharmaceuticals (ALNY), the second-largest name on the list, saw its revenue grow 95.1% over the last twelve months and trades at 34.0 times trailing earnings. Synopsys (SNPS) itself posted revenue growth of 39.5% and trades at 92.2 times trailing earnings. This is not the case for every company here; Lennox International (LII), for example, saw its revenue decline 2.1% over the same period.
A low price is a starting point, not a conclusion.
A 52-week-low list is a screen for dislocation, not a simple shopping list. A stock can arrive here because its business has deteriorated, or because the market has repriced its future. The disciplined move is to investigate the business behind the ticker before reacting to the price itself. The numbers tell a story that the stock chart alone cannot.
If any of these names tempt you, resist buying a price alone. Our Buy the Dip screen asks the follow-up question that matters: which marked-down stocks still have the growth and cash generation to recover.
Catching Falling Prices Is A Skill. Not Needing To Is A Strategy
Buying stocks at 52-week lows works brilliantly on the survivors and painfully on the rest, and nobody rings a bell to tell you which is which. The honest answer for most investors is to stop needing that call.
The Trefis High Quality (HQ) Portfolio holds roughly 30 businesses selected for the traits that make recoveries likely in the first place: consistent cash generation, strong margins, resilient balance sheets. It has a track record of outpacing a benchmark that combines all major indices – the S&P 500, S&P Mid-cap, and Russell 2000. Watch the low list for information; let a disciplined basket do the buying.